MedPath

GSK-2618960

Generic Name
GSK-2618960

Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers

Phase 1
Completed
Conditions
Autoimmune Diseases
Interventions
Drug: Placebo
First Posted Date
2014-11-18
Last Posted Date
2017-05-09
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
18
Registration Number
NCT02293161
Locations
🇬🇧

GSK Investigational Site, Cambridge, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath